Polaris Genomics identifies genomic biomarkers to support the development of psychiatric drugs and clinical tools.
Polaris Genomics has raised $250K in total funding. The most recent round was Debt Financing. The last funding was announced in August 2025.
Polaris Genomics's investors include Wing Venture Capital, Google for Startups, Stony Lonesome Group, Viking Global Investors, Sanford Health.
Polaris Genomics is headquartered in Gaithersburg, United States.
Polaris Genomics identifies genomic biomarkers to support the development of psychiatric drugs and clinical tools.
Polaris Genomics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Polaris Genomics — Funding & Investors." VCBacked, August 26, 2025, https://www.vcbacked.co/company/polaris-genomics. Accessed September 30, 2026.
VCBacked. (2025). Polaris Genomics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/polaris-genomics
{{cite web |title=Polaris Genomics — Funding & Investors |url=https://www.vcbacked.co/company/polaris-genomics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated